Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in Middle East in October 2024

Last updated: Oct 2024 A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Middle east. We rank investors based on the number of investments they made in Life science companies from Middle east. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in Middle East in October 2024

Investor	Life Science Middle East investments
TRANGELS	4
Egypt Ventures	4
Integra Holdings	4
Pitango VC	3
Israel Innovation Authority	3
OrbiMed	3
Neo Ventures	3
Sapir Venture Partners	3
Endure Capital	2
fresh.fund	2
Johnson & Johnson Robotics and Digital Solutions	2
Minrav	2
Takeda Ventures	2
Oryx Fund	2
Arancia International	2
Genesis Park	2
Cairo Angels	2
Averroes Ventures	2
SOSV	2
Pontifax	2
Cancer Focus Fund	2
LoftyInc Capital	2
PeakBridge	2
FutuRx	2
aMoon Fund	2
Arba Finance Ltd.	1
Remiges Ventures	1
Milk and Honey Investments	1
Stony Hill Corp	1
Emirates Angels	1
M Ventures	1
HBL Hadasit Bio Holdings	1
Almoayed Ventures	1
First Star Ventures	1
Khwarizmi Ventures	1
RM Global Partners	1
Grove Ventures	1
Alex Angels	1
Knuru Capital	1
Ibtikar Fund	1
S3 Ventures	1
Jerusalem Venture Partners (JVP)	1
Boehringer Ingelheim Venture Fund	1
Arkin Holdings	1
Alexandria Fund	1
Hult Alumni Angels	1
Pfizer	1
Life Science Angels	1
Office of the Chief Scientist	1
Talisman Capital Partners	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Early Stage Investment Fund and Network

Investment focus

Biotechnology, Energy, Manufacturing
Seed, Pre-Seed, Angel
Turkey, United States, Estonia

Portfolio highlights

& New Me — Explore the best aesthetic treatments in Turkey with New Me. Book a consultation, read reviews, and find the right doctor for your beauty journey.
Winfluencer — Winfluencer is a platform for automated digital influencer marketing. Their solutions are machine learning, augmented reality, image processing, data analytics, social media analytics, and fraud detection. Winfluencer connects thousands of e-commerce sites through a single platform and an automated system. Because of the new generation affiliatemarketing approach, this system enables users to generate long-term income. Its transparent structure allows both users and the e-commerce site to track sales generated by their interactions.
Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Series A
Egypt, United States, The Netherlands

Portfolio highlights

Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
Gahez Market — Gahez Market Online store
Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Investment focus

Biotechnology, Pharmaceutical, Life Science
Seed, Series B, Series F
Israel

Portfolio highlights

BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Investment focus

Software, Health Care, Information Technology
Series A, Series B, Series C
Israel, United States, China

Portfolio highlights

Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Investment focus

Health Care, Biotechnology, Medical Device
Grant, Seed, Pre-Seed
Israel, United States, Mali

Portfolio highlights

BloomX — Helping nature do its magic with the power of technology
Pickommerce — Pickommerce specializes in robotic grasping and focused on logistic solutions, primarily with our autonomous Pick & Pack integrated system. We are on a mission to promote work productivity and facility efficiency in logistic warehouses while ensuring seamless operation.
NurExone Biologic — NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Chemomab — Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases
MBX Biosciences — Homepage - MBX Biosciences
Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Investment focus

Software, Artificial Intelligence, Aerospace
Seed, Funding Round, Series A
Israel, United Kingdom, Estonia

Portfolio highlights

EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Early Stage VC

Investment focus

Software, Biotechnology, Machine Learning
Seed, Pre-Seed, Series A
Israel, United States, United Kingdom

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.

Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.

Investment focus

Health Care, Software, E-Commerce
Seed, Series A, Series B
Egypt, United States, United Kingdom

Portfolio highlights

Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
Pylon — Reliable smart energy solutions within the reach of emerging markets.
Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Investment focus

Health Care, FinTech, Education
Seed, Pre-Seed, Series A
Israel, United States, Norway

Portfolio highlights

enso — enso offers AI-powered bot bundles to automate your marketing strategy. Perfect for small business owners, our bots handle social media, SEO, lead generation & much more. Start with a 7 days free trial or talk with one of our marketing experts today.
Carbon Blue — Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri.
Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.

Healthcare innovation wherever it originates.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Israel, United Kingdom

Portfolio highlights

Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Minrav provides engineering and construction services.

Investment focus

Health Care, Hospital, Wellness
Series A, Funding Round
Israel, Malaysia

Portfolio highlights

iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.

Investment focus

Information Technology, FinTech, Software
Seed, Pre-Seed, Series A
United Arab Emirates, Saudi Arabia, Egypt

Portfolio highlights

Growdash — Growdash is a business intelligence and analytics tool built specifically for restaurants to support profitable growth strategic decisions across online sales channels.
Penny Software — Simple. Spending. Software.As above. But, more specifically, penny is a cloud-based Procure-To-Pay system. penny helps you digitize and manage your full procurement cycle from request to approval. Manage RFQs to vendors, compare quotations, send POs and even payment. penny was designed to make things easy and consolidate all of yourorganization’s spending needs into one intelligent system
Merit Incentives — Merit Incentives provides gifts, rewards, and engagement strategies using innovative technologies in the MENA region.

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Investment focus

Health Care, Biotechnology, Life Science
Series A, Series B, Funding Round
Israel, United States, Malaysia

Portfolio highlights

NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Investment focus

Manufacturing, Construction, Health Care
Private Equity, Debt Financing, Funding Round
United States, Israel

Portfolio highlights

The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
Conditioned Air — Conditioned Air is South Florida's premier air conditioning contractor with 60 years of experience. Serving Naples, Venice, Ft. Myers, Englewood, Port Charlotte, Sarasota, Bradenton & Surrounding Areas.

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Investment focus

E-Commerce, Mobile, Marketplace
Seed, Angel, Pre-Seed
Egypt, United States, Lebanon

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Sprints — home page Description
The Fashion Kingdom — Fashion, Sneakers for men, women, and kids

Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.

Investment focus

Transportation, Logistics, Delivery
Seed, Convertible Note
Egypt, United Arab Emirates

Portfolio highlights

ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Seed, Series A
Israel, United States, Germany

Portfolio highlights

Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
ImmunoGenesis — We are rapidly translating the most cutting-edge discoveries from academic tumor immunology into drugs optimized for treating the majority of patients who have "cold" cancers refractory to currently available immunotherapy.
March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity

LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
Nigeria, United States, Egypt

Portfolio highlights

Mtor — Mtor is an online marketplace that is reshaping the automotive aftermarket and provides sophisticated technology solutions.
EMTECH — EMTECH provides solutions for Digital Currency regulatory compliance, development and management to help Central Banks and FinTechs build, run and manage modern financial systems.
Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.

PeakBridge is an Alternative Investment Fund Manager and Investment Services Firm specialized in FoodTech.

Investment focus

Food and Beverage, Food Processing, Health Care
Seed, Series A, Funding Round
Israel, United States, United Kingdom

Portfolio highlights

Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Investment focus

Biotechnology, Life Science, Biopharma
Seed, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.

aMoon is a leading healthtech & life sciences venture capital firm.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Israel, Switzerland

Portfolio highlights

AltruBio — AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment ofcancer and immune-related inflammatory diseases.With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for unmet medical needs.Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics.Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.
Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
Ibex Medical Analytics — Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. It combines AI, data science, image analysis and machine learning technologies and applies them to cancer diagnostics in digital pathology.

Investment banking boutique based in Tel Aviv since 1978.

Investment focus

AgTech, Medical, Cannabis
Series A
Israel

Portfolio highlights

GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Japan, Canada

Portfolio highlights

Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.

Investment focus

Life Science, Organic Food, Biotechnology
Series A
Israel

Portfolio highlights

BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.

A Diversified Company focused on multiple area of the cannabis hemp and CBD industry.

Investment focus

AgTech, Medical, Cannabis
Series A
Israel

Portfolio highlights

GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

investing in the future.

Investment focus

Health Care, Life Science
Pre-Seed
United Arab Emirates

Portfolio highlights

Takalam — Takalam is an online counseling platform for a digital solution for mental well-being.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Switzerland, United Kingdom

Portfolio highlights

CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Series A, Series B
Israel

Portfolio highlights

ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.

Almoayed Ventures is the venture arm of Almoayed General W.L.L. The company focuses on partnering with investment professionals with a track record of supporting and scaling innovative businesses. The company also makes direct investments in passionate entrepreneurs and supports them throughout their journey.

Investment focus

Health Care, Information Technology, Financial Services
Seed, Series A, Pre-Seed
United States, India, United Arab Emirates

Portfolio highlights

BizzTM — BizzTM is a company that provides a variety of e-commerce categories of products through an aggregated delivery model.
Ridepanda — Employer sponsored leases on the widest selection of pedal bikes, e-bikes and e-scooters from top brands.
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.

Investing with conviction in visionary, technical founders inventing the future.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Pre-Seed, Series A
United States, Canada, Israel

Portfolio highlights

Zanskar — Zanskar develops a predictive platform informed by massive data for discovering previously unknown geothermal resources. Its platform includes subsurface characterization technology and massive data sets, enhancing and reducing risk in the exploration of geothermal resources.
Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
Bedrock Energy — Bedrock Energy is developing drilling technology and advanced subsurface simulation software to enable geothermal heating and cooling. The company develops autonomous drilling technology and advanced subsurface simulation software to make geothermal heating and cooling more widespread, affordable, and accessible.

Khwarizmi Ventures is a venture capital firm that seeks investments in startups with a passion for algorithms. It seeks to help create their vision, as they embark on a journey together that aligns their goals to improve quality of life using technology powered by algorithms. .

Investment focus

E-Commerce, FinTech, Software
Seed, Series A, Pre-Seed
Saudi Arabia, Egypt, United Arab Emirates

Portfolio highlights

Yalla Plus — Yalla Plus offers QR-based digital menu solutions for restaurants, featuring integrated payments and easy menu management.
Bluworks.io — Bluworks.io is a HRTech SaaS platform offers cloud-based solutions.
Simplified Financial Solutions Company — Simplified Financial Solutions Company offers startups and SMEs financial management solutions including the ability to issue virtual and physical corporate cards, manage spending and automate expense reporting.

RM Global is an investment banking and strategic advisory firm dedicated to creating unique value for its clients and investors. We specialize in Life Sciences, including pharmaceuticals, medical devices, biotechnology, healthcare IT/digital health, and diagnostics. Our broad international reach includes the Americas, Europe, Israel, and Asia.Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and financial advice, based upon our comprehensive industry experience. Several of our partners were senior management of Roberts Mitani, which completed over $3 billion in M&A and strategic transactions and raised over $200 million in private growth and venture capital for clients. We take pride in our long term relationships with our clients that span many years.We leverage our unique global network of leading corporations, investment funds, institutional and strategic investors, family offices, industry experts and management teams to source and execute transactions that build new opportunities for our clients worldwide.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Series B
Israel, United States

Portfolio highlights

BIOMx — Developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases.
Mitoconix Bio — Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.Mitochondria generates ATP, the energy source for all cellular activities. Mitochondria are also involved in other essential cellular functions, including calcium sequestration, amino acid and lipid metabolism,keeping balanced redox potential and orchestrating programmed cell death. In neurons in particular, mitochondria are very dynamic organelles that constantly undergo fission (division) and fusion. This process, called mitochondrial dynamics, is critical in maintaining healthy and functional mitochondria under both normal conditions and in response to stress and in ensuring having viable mitochondria along the axons and in the synaptic boutons. A defect in either fusion or fission limits mitochondrial motility, decreases energy production, increases oxidative stress and activates pro-apoptotic signaling thereby promoting cell dysfunction and death.Mitoconix’ lead drug is a first-in-class inhibitor of pathological mitochondrial fragmentation and dysfunction with demonstrated in vivo efficacy in animal models of Huntington’s (HD) and Parkinson’s diseases (PD) and beneficial activity in patient-derived cells of HD, sporadic and genetic PD, and sporadic and genetic Alzheimer’s disease (AD).
ImmPACT Bio — ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Investment focus

Artificial Intelligence, Machine Learning, Software
Seed, Series A, Series B
Israel, United States

Portfolio highlights

NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
DeepChecks — Continuous validation for machine learning. Validate and monitor your data and models during training, production and new version releases.

Alex Angels is an investment management company that helps investors to invest in early-stage companies with strong management teams. The company specializes in the fields of financial services, financial exchange, and investments. Alex Angels was founded in 2016 and headquartered in Al Iskandariyah, Egypt.

Investment focus

E-Commerce, Marketplace, Mobile Apps
Seed, Pre-Seed, Convertible Note
Egypt

Portfolio highlights

CardoO — Welcome To Our InnovationsExplore
SIDEUP — SIDEUP provides you with all the necessary tools to grow your business through a hassle-free experience from local and global logistics support, storage services, and innovative and real-time dashboards.
Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.

Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.

Investment focus

E-Commerce, Information Technology, Financial Services
Series A, Funding Round, Series C
United Arab Emirates, Spain, Kenya

Portfolio highlights

Savana — Transform EMR into Deep-Real World Evidence with a scientific methodology that applies Artificial Intelligence (AI) to EMR free-text.
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes

Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.

Investment focus

Artificial Intelligence, E-Commerce, Information Technology
Seed, Pre-Seed, Funding Round
Palestinian Territory, United States, Jordan

Portfolio highlights

DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Algebra Intelligence — Algebra Intelligence is a software development firm that integrates artificial intelligence solutions into the energy sector by providing comprehensive asset performance management, proactive notifications, predictive maintenance, and energy forecast.

Venture Capital Firm

Investment focus

FinTech, Health Care, Life Science
Pre-Seed, Series A
United Arab Emirates

Portfolio highlights

InvestSky — InvestSky offers zero commission investing in your favorite stocks. Invest smarter, together. Trading mobile app is coming soon, join the waitlist!
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.

JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.

Investment focus

Software, Cyber Security, Enterprise Software
Series A, Series B, Seed
United States, Israel, United Kingdom

Portfolio highlights

Akeyless Security — The #1 Vault Alternative secures credentials, certificates and keys securely and with ease across multi-cloud environments.
Chain Reaction — Chain Reaction is engineering the future of disruptive blockchain and privacy technologies by accelerating compute and mining hardware performance.
Secret Double Octopus — Provider of industry-leading FIDO-certified, rotation-based passwordless MFA with the fullest support for enterprise complexity. Click here for more!

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Funding Round
Israel, United States, Switzerland

Portfolio highlights

MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.

Alexandria Fund

Investment focus

Biopharma, Life Science, Biotechnology
Seed
Egypt

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.

Hult Alumni Angels

Investment focus

Biopharma, Life Science, Biotechnology
Seed
Egypt

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.

Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Post-IPO Equity, Series A, Corporate Round
United States, Israel, France

Portfolio highlights

CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Seed, Series A
United States, Israel, The Netherlands

Portfolio highlights

InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Investment focus

Health Care, Biotechnology, Hardware
Seed
Israel

Portfolio highlights

LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.

Talisman Capital Partners operates as a private investment company.

Investment focus

Information Services, Pet, News
Series A, Seed, Series B
United States, Israel, Hong Kong

Portfolio highlights

Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
qServe Communications — I found a great domain name for sale on Dan.com. Check it out!

Investors by industry

Artificial intelligence

Impact

Media (entertainment)

Proptech

Marketplace

Community